Healthcare Industry News: Terumo
News Release - April 17, 2006
Terumo Cardiovascular Systems and Harvest Technologies Corporation Announce Exclusive Distributorship in the Cardiovascular Market for Harvest's SmartPReP(R)2 Platelet Concentration SystemANN ARBOR, Mich., April 17 (HSMN NewsFeed) -- Terumo Cardiovascular Systems and Harvest Technologies Corporation announce that Terumo Cardiovascular Systems has become the exclusive distributor for Harvest's SmartPReP®2 Platelet Concentration System in the USA and Canada in the cardiovascular and perfusion markets, effective April 1, 2006.
Harvest Technologies has a rich tradition of innovative technologies that improve surgical outcomes by harvesting and concentrating proteins. The SmartPReP2 System incorporates a proprietary floating shelf disposable technology which provides the highest platelet concentration, in the shortest time, and with the least variability. In the hands of clinicians, this concentrate acts to accelerate the wound healing process.
Terumo Cardiovascular Systems' experience in sales and marketing and its knowledge of the cardiovascular and perfusion markets will open doors for the SmartPReP platform to expand into the cardiac surgery area. For more information, contact Peter Wojcik at peter.wojcik@Terumomedical.com or (734) 741-6081.
Terumo Cardiovascular Systems Corporation manufactures and markets products for the global cardiac surgery, interventional and neurovascular markets. It is headquartered in Ann Arbor, Michigan with manufacturing operations in Ann Arbor, as well as Elkton, Maryland; Ashland, Massachusetts; and Tustin, California. It is one of several subsidiaries of Terumo Corporation of Japan focused exclusively on the cardiac and vascular markets, including Vascutek-Terumo, developer of vascular grafts; and Terumo Heart Inc., developer of a ventricular assist device. For more information, visit http://www.Terumo-cvs.com/for_clinicians/optimizing .
Terumo Corporation is a premier global medical device company with 2004 annual sales in excess of $2.3 billion. Founded in 1921, the company develops, manufactures and distributes world-class medical devices for use in cardiothoracic surgery, interventional procedures, transfusion medicine, and needle and syringe products. Terumo contributes to society by providing valued products and services in the healthcare market and by responding to the needs of healthcare providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543:JP) and is a component of the Nikkei 225, Japan's leading stock index.
Headquartered in Plymouth, Massachusetts, Harvest Technologies Corporation is dedicated to improving surgical outcomes through the development of unique technologies that separate and concentrate cellular components found in blood and bone marrow to accelerate the normal healing process. For more information, visit http://www.harvesttech.com .
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.